Spandidos Publications

We are pleased to report on the latest Impact Factor information (2024 Journal Citations Reports®  from Clarivate Analytics) for Spandidos Publications, as shown in tabulated form below.

Aged garlic extract may boost memory and reduce anxiety as the brain ages, according to new preclinical research 🍃🧠 Curious about the science behind it? Read more: news-medical.net/news/20251116/… #Garlic #Neuroscience #Aging @SpandidosP

Un artículo publicado en @SpandidosP destaca los mecanismos por lo cuales los metabolitos microbianos pueden remodelar el microambiente tumoral, lo que implica mejoras en los tratamientos oncológicos y pronóstico de los pacientes. #Neurology #Cancer spandidos-publications.com/10.3892/ijo.20…

My research is available on @ResearchGate: researchgate.net/publication/39… @SpandidosP

Our new paper Potential of doxofylline in the treatment of chronic obstructive airway diseases spandidos-publications.com/10.3892/br.202…

#NowOnLine Our latest article "Chimeric PD‑1 receptor redirects primary T cells against childhood solid tumors but not to PD‑1 ligand‑positive CD80‑coexpressing cells" is published in @mol_med @SpandidosP #PediatricOncology #Immunotherapy #小児科血液研究室 spandidos-publications.com/10.3892/mmr.20…

We thank all stakeholders associated with Spandidos Publications, including our Editorial Board and reviewers, for helping us to achieve these results.

International Journal of Molecular Medicine and International Journal of Oncology have remained in Quartile (Q)1 of their respective categories, whereas Oncology Reports and Molecular Medicine Reports are in Q2.

We are pleased to report on the latest Impact Factor information (2024 Journal Citations Reports®  from Clarivate Analytics) for Spandidos Publications, as shown in tabulated form below.

Happy to share our very fresh paper as always on hot Respiratory topic! Special thanks to Vaso Georgakopoulou! @SpandidosP spandidos-publications.com/10.3892/etm.20…

We thank all stakeholders associated with Spandidos Publications, including our Editorial Board and reviewers, for helping us to achieve these results.

International Journal of Oncology, Oncology Reports, International Journal of Molecular Medicine, Molecular Medicine Reports and Biomedical Reports have remained in Quartile (Q)1 of their respective categories; and Oncology Letters and World Academy of Sciences Journal are in Q2.

We are pleased to report on the new 2024 "CiteScores" data which have been released by Scopus, and the portfolio of Spandidos journals have continued to fare well according to these metrics, as shown in the attached Table.

Our latest study on B/F/TAF treatment switch in PLWH! Enjoy! spandidos-publications.com/10.3892/br.202… @SpandidosP

Iron metabolism and its contribution to cancer (Review) spandidos-publications.com/10.3892/ijo.20… International Journal of Oncology via @SpandidosP

Topical calcineurin and mammalian target of rapamycin inhibitors in inflammatory dermatoses: Current challenges and nanotechnology‑based prospects (Review) spandidos-publications.com/10.3892/ijmm.2… @SpandidosP

Our research on the novel anti-androgen inhibitor ADA-308, aimed at targeting adenocarcinoma and overcoming resistance in enzalutamide-resistant prostate cancer is now published! Read here: spandidos-publications.com/10.3892/or.202… @FJ_Scientist @NakisaTabrizian @AminaZoubeidi @SpandidosP

Here, at Spandidos Publications, we would like to thank all our authors, reviewers, Editorial Boards and Academies, and office staff in Athens and London for their contributions to these achievements.

The latest Impact Factor for Molecular and Clinical Oncology, according to Journal Citation Reports 2023 (Clarivate), is 1.4 [ranked Q4 (263/322) in the Oncology category of journals].

The latest Impact Factor information (2023 Journal Citations Reports®  from Clarivate Analytics) for Spandidos Publications are shown in tabulated form below.